Mesoblast

MESONasdaq Australia Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.014 B

$15.48 +2.31%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1,296,862,776

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#33Kodiak SciencesKOD$2.04B
#34VericelVCEL$2.03B
#35MesoblastMESO$2.01B
#36Vir BiotechnologyVIR$1.84B
#37Hemab TherapeuticsCOAG$1.77B

What if Mesoblast were worth as much as…

Open the what-if tool →

Gold $30.3T

$232,725.51

Per share 15,034× higher

Bitcoin $1.72T

$13,220.63

Per share 854× higher

Nvidia $5.48T

$42,125.27

Per share 2,721× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Mesoblast are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.